A. Melander - Concepedia

Author

A. Melander

Lund University

Also Known As

A MELANDER, A Melander, A. MELANDER, A. Melander, Arise Melander

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Lund University Malmö University Skaraborg Hospital Karolinska Institutet Karolinska University Hospital

About

A. Melander is an author at Lund University specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	19	857
2	Health Sciences	7	7	226
3	Public Health	3	3	72
4	Anesthesia	1	1	14
5	Biochemistry	1	1	21

A. Melander

Publications

1.1K

Citations

H-Index

Page 1

	Year	Citations
Utilisation of antihyperglycaemic drugs in ten European countries: different developments and different levels A. Melander, Pietro Folino-Gallo, T Walley, Diabetologia Diabetes ManagementDrug DiscoveryChronic Kidney DiseasePharmacologyInternational Health	2006	280
Associations between smoking and β‐cell function in a non‐hypertensive and non‐diabetic populationSkaraborg Hypertension and Diabetes Project Carl Johan Östgren, Ulf Lindblad, Jonas Ranstam, Diabetic Medicine	2000	80
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period. Dorte Worm, Jan Erik Henriksen, Allan Vaag, The Journal of Clinical Endocrinology & Metabolism Antilipolytic Drug AcipimoxPharmacotherapyObesityMetabolic SyndromeAcipimox Treatment	1994	62
Pharmacokinetics of glibenclamide and its metabolites in diabetic patients with impaired renal function A. J�nsson, Tony Rydberg, A. Melander, European Journal of Clinical Pharmacology Renal FunctionMedicineDiabetesPharmacologyDiabetic Kidney Disease	1998	61
Glucose tolerance and mortality, including a substudy of tolbutamide treatment William C. Knowler, G. Sartor, A. Melander, Diabetologia ObesityMetabolic SyndromeGlucose ToleranceDiabetes ManagementDiabetes	1997	58
Bioavailability of acetylsalicylic acid and salicylic acid from rapid-and slow-release formulations, and in combination with dipyridamol B. Brantmark, E. W�hlin-Boll, A. Melander European Journal of Clinical Pharmacology Pharmaceutical ScienceAcetylsalicylic AcidMedicineRelease MechanismPharmacology	1982	50
Drug prescription attitudes and behaviour of general practitioners Anders Ekedahl, Sven Ingmar Andersson, Birgitta Hovelius, European Journal of Clinical Pharmacology Family MedicineSubstance AbusePrimary CareSubstance UseDrug Prescription Attitudes	1995	47
Glycaemic control, disease duration and β‐cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project Carl Johan Östgren, Ulf Lindblad, Jonas Ranstam, Diabetic Medicine	2002	47
Oral Antidiabetic Drugs: an Overview A. Melander Diabetic Medicine GlycobiologyInsulin SignalingMetabolic SyndromeInsulin DeliveryHealth Sciences	1996	41
EQUIANALGESIC EFFECTS OF PARACETAMOL AND INDOMETHACIN IN RHEUMATOID ARTHRITIS Peter Seideman, A. Melander Lara D. Veeken Rheumatoid DisorderRheumatologyAnti-inflammatorySteady StatePharmacological Study	1988	39

Page 1